ArticleVaccine2022

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.

Carolina Porras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.